Eye Infections Market and Vision Disorders Clinical Trials H2 2015 Review in New Research Reports

PUNE, India, September 11, 2015 /PRNewswire/ --

Market research reports titled Eye Infections Global Clinical Trials Review, H2, 2015 and Vision Disorders Global Clinical Trials Review, H2, 2015 are new additions to the pharmaceuticals business intelligence collection of LifeScienceIndustryResearch.com.

Complete report on eye infections market for clinical trials review of H2 2015 spread across 77 pages, providing clinical trial overviews of 10 companies, 9 educational / government institutes and supported with 45 tables and 24 Figures is now available at http://www.lifescienceindustryresearch.com/eye-infections-global-clinical-trials-review-h2-2015.html .

The latest clinical trial report on global eye infections market for H2, 2015 review provides an overview of Eye Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Eye Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

One of the major reasons to buy this eye infections market clinical trials review report is that it assists in formulating key business strategies with regards to investment and also helps in identifying prominent locations for conducting clinical trials which saves time and cost. The research provides top level analysis of eye infections global clinical trials market which helps in identifying key business opportunities and support understanding of trials count and enrollment trends by country in global eye infections therapeutics market. The report also aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials and facilitates clinical trial assessment of the indication on a global, regional and country level.

Clinical trial overview of the eye infections market companies like Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Laboratoires Thea S.A., Novartis AG, InSite Vision Incorporated, Alcon, Inc., Ajanta Pharma Limited, SIFI S.p.A, Dompe Farmaceutici S.p.A. and Allergan Plc are covered in this research for H2 2015. Eye infections clinical trial overview of educational and/or government institutes like Federal University of Sao Paulo, National Eye Institute, University of California, Los Angeles, Chulalongkorn University, Massachusetts Eye and Ear Infirmary, University of California, San Francisco, University of Sao Paulo, University of Tsukuba, All India Institute of Medical Sciences and Ann & Robert H. Lurie Children's Hospital of Chicago is also covered in this report.  Order a copy of Eye Infections Global Clinical Trials Review, H2, 2015 at http://www.lifescienceindustryresearch.com/purchase?rname=55193 .

The second research titled Vision Disorders Global Clinical Trials Review, H2, 2015 provides a snapshot of the global vision disorders market clinical trials landscape with top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status. The research reviews top companies involved in vision disorders clinical trials and enlists all trials (Trial title, Phase, and Status) pertaining to the company. It provides all the unaccomplished vision disorders clinical trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment while offering enrollment trends for the past five years. Report also provides latest news on clinical trials of vision disorders market for the past three months. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned in this vision disorders clinical trials review report include Novartis AG, ThromboGenics NV, Celerion, Inc., C. H. Boehringer Sohn AG & Co. KG, Allegro Ophthalmics, LLC, Beyond Blue Limited, Bayer AG, Asociacion para Evitar la Ceguera en Mexico I.A.P., Alcon, Inc. and Alberta Innovates- Health Solutions. Vision disorders clinical trial overview of U.S. Department of Veterans Affairs, National Eye Institute, Postgraduate Institute of Medical Education and Research, Case Western Reserve University, Charite - Universitatsmedizin Berlin, Dong Rae Bong Seng Hospital, Jaeb Center for Health Research, L.V. Prasad Eye Institute, Moorfields Eye Hospital NHS Foundation Trust and Neurological Institute of Colombia are covered in this report. Supported with 45 tables, 23 figures and spread across 99 pages, the Vision Disorders Global Clinical Trials Review, H2, 2015 market research report is available at http://www.lifescienceindustryresearch.com/vision-disorders-global-clinical-trials-review-h2-2015.html .

Explore more reports on the pharmaceuticals market at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .

About Us:
Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
[email protected]

Connect with Us: 

G+ / Google Plus: https://plus.google.com/112612135957880308475/about

Twitter: https://twitter.com/LifeSciReports

RSS / Feeds: http://www.lifescienceindustryresearch.com/feed